12:00 AM
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

BioParadox preclinical data

In a pig model of MI, VitaKine PCT significantly improved ejection fraction by 23% vs. both standard platelet rich plasma (PRP) and no treatment...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >